¶ AstraZeneca COVID-19 vaccine
This page has moved! Click here to view the most up-to-date version of this page on the White Rose Wiki.
The AstraZeneca COVID-19 vaccine is a genetic vaccine product developed by AstraZeneca in partnership with Verity Pharmaceutics, Serum Institute of India (SII) and the University of Oxford. It is known in various contexts as ChAdOx1, ChAdOx1-S or AZD1222 and by its brand names, Vaxzevria or Covishield.
¶ History
In June 2020, AstraZeneca and Emergent BioSolutions partnered to manufacture their COVID-19 vaccine product.[1][2]
Health Canada authorized the vaccine under interim order on February 26, 2021.[3]
On May 11, 2021, Alberta Health announced it would no longer offer "first doses" of the AstraZeneca product due to supply issues.[4]
It was approved by Health Canada under the Food and Drug Regulations on November 18, 2021.[5]
¶ Documents
- December 16, 2022: Product Monograph
¶ National contracts
South Africa
Between the Serum Institute of India, Serum Life Sciences and the National Department of Health of South Africa.
- January 7, 2021: Term Sheet
- January 16, 2021: Vaccine Purchase Agreement
¶ Clinical trials
- COV001
- COV002
- A Study of a Candidate COVID-19 Vaccine (COV003)
¶ External links
Blankenship, K. (2020, June 11). AstraZeneca, Emergent BioSolutions sign $87M deal to produce U.S. supply of COVID-19 vaccine. Fierce Pharma. http://archive.today/2022.05.12-232222/https://www.fiercepharma.com/manufacturing/astrazeneca-emergent-biosolutions-sign-87m-deal-to-produce-u-s-supply-covid-vaccine ↩︎
Neri, M. B. (2020, June 11). Emergent BioSolutions Signs Agreement to be U.S. Manufacturing Partner for AstraZeneca’s COVID-19 Vaccine Candidate. Emergent BioSolutions. http://archive.today/2022.05.12-231724/https://investors.emergentbiosolutions.com/news-releases/news-release-details/emergent-biosolutions-signs-agreement-be-us-manufacturing-0?field_nir_news_date_value[min]= ↩︎
Regulatory Decision Summary - AstraZeneca COVID-19 Vaccine - Health Canada. (2021, February 26). Government of Canada. https://web.archive.org/web/20230610043020/https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detailTwo.html?linkID=RDS00772 ↩︎
Snowdon, W. (2021, May 11). Alberta stops offering first doses of AstraZeneca COVID-19 vaccine due to supply issues. CBC News. http://archive.today/2021.05.11-213711/https://www.cbc.ca/news/canada/edmonton/astrazeneca-covid-19-vaccine-alberta-1.6021739 ↩︎
Regulatory Decision Summary - Vaxzevria - Health Canada. (2021, November 18). Government of Canada. https://web.archive.org/web/20230610054136/https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detail.html?linkID=RDS00889 ↩︎